About BioGenex

BioGenex provides a “Total Solution” for slide-based cell and tissue analysis to accelerate clinical diagnostics and drug discovery development. We have developed the total walk-away, industrial-scale automated systems to streamline and standardize an array of processes for cell and tissue testing in immunohistochemistry (IHC), in situ hybridization (ISH), Fluorescent in situ hybridization (FISH), special stains.

Our products include more than 400 antibodies (monoclonal and polyclonal) for various cancer panels, highly sensitive detection kits, automated systems, mRNA, miRNA, and FISH probes, ancillary reagents, and consumables. We accommodate diverse laboratory needs with an array of clinical and research automation platforms that meet global quality standards (ISO 13485 & ISO 9001), are approved by the FDA and CE-marked. BioGenex is a global market leader in molecular pathology providing customer-centric solutions for complete automation of cell and tissue staining. Through its cutting-edge and patented technologies, the company has transformed the practice of slide-based staining in many molecular pathology laboratories.


The diagnostic requirement of immunohistochemistry (IHC) has been an increasing trend that demands an increase in more reliable methods for automating the workflow. Even though immunostaining is not a complex assay as it involves several steps and is usually depends on a skilled technician for successful execution. The need for automation is on high demand for the reasons for increasing volumes, reliability, reproducibility, and quality. Automaton of IHC workflow offers several advantages like protocol standardization, traceability, and walkaway operation.

BioGenex has been a pioneer in immunohistochemistry including the first-ever discovery of heat-induced antigen retrieval methods. BioGenex designs develop and commercialize molecular pathology systems for cancer diagnosis, prognosis, precession medicine, and life science research. BioGenex prides itself on delivering cutting edge technology, years ahead of its competition, providing the finest systems for immunohistochemistry, in situ hybridization, Fluorescent in situ hybridization, special stains and in situ PCR. 

Quick Inquiry Form